15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles

15.2 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles

1. Endocrine Pathology: Pituitary, Thyroid, and Adrenal Axis

Pituitary Pathology

• Pituitary Adenomas: Benign monoclonal tumors of the anterior pituitary classified by hormone secretion:
  • Prolactinoma (30%): Hypersecretion of prolactin causes hypogonadism, amenorrhea, galactorrhea, and infertility in women; loss of libido and erectile dysfunction in men. Compression of optic chiasm leads to bitemporal hemianopsia.
  • Somatotroph Adenoma: Growth hormone (GH) excess stimulates hepatic IGF-1 production. Causes gigantism in children (prior to epiphyseal plate closure) and acromegaly in adults (enlarged hands/feet, coarse facial features, prognathism, insulin resistance).
  • Corticotroph Adenoma: ACTH hypersecretion leads to bilateral adrenal hyperplasia and Cushing disease.
• Hypopituitarism (Sheehan Syndrome): Ischemic necrosis of the anterior pituitary following severe postpartum hemorrhage. During pregnancy, the pituitary enlarges to twice its normal size without a proportional increase in blood supply; intrapartum shock leads to pituitary infarction. Manifests as failure to lactate (prolactin deficiency), severe fatigue, secondary hypothyroidism, and adrenal insufficiency.

Thyroid Pathology & Neoplasia

• Hypothyroidism:
  • Hashimoto Thyroiditis: Most common cause of hypothyroidism in iodine-sufficient regions. Autoimmune destruction of thyroid tissue mediated by anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies. Histology demonstrates dense lymphocytic infiltrates with germinal centers and follicular epithelial cells with abundant eosinophilic granular cytoplasm (H\u00fcrthle cells). Increased risk of Primary Thyroid Lymphoma (DLBCL).
  • Cretinism: Severe congenital hypothyroidism causing intellectual disability, short stature, umbilical hernia, and coarse facial features.
• Hyperthyroidism:
  • Graves Disease: Most common cause of hyperthyroidism. Type II hypersensitivity mediated by thyroid-stimulating immunoglobulin (TSI), an autoantibody that activates TSH receptors. Manifests with diffuse toxic goiter, exophthalmos (retro-orbital fibroblast proliferation and glycosaminoglycan accumulation driven by T-cells), and pretibial myxedema.
• Thyroid Malignancies:

Adrenal Pathology

• Cushing Syndrome: Clinical state of chronic hypercortisolism.
  • Etiologies: Exogenous corticosteroid administration (most common overall); ACTH-dependent Cushing disease (pituitary corticotroph adenoma, high ACTH); ACTH-independent adrenal adenoma/carcinoma (low ACTH); Ectopic ACTH secretion (small cell lung carcinoma, markedly elevated ACTH).
  • Manifestations: Central obesity, moon facies, buffalo hump, abdominal purple striae (collagen cleavage), proximal muscle weakness, osteoporosis, hypertension, and hyperglycemia.
• Addison Disease (Primary Adrenal Insufficiency): Autoimmune destruction of all three zones of the adrenal cortex (90% of cases in developed nations) or infectious destruction (tuberculosis in developing nations).
  • Manifestations: Deficiency of aldosterone and cortisol leads to hyponatremia, hyperkalemia, metabolic acidosis, hypotension, hypoglycemia, and profound fatigue. High compensatory POMC synthesis yields elevated ACTH and MSH, causing characteristic skin and mucosal hyperpigmentation.
• Pheochromocytoma: Tumor of chromaffin cells originating from the neural crest in the adrenal medulla.
  • Pathophysiology: Secretes excess catecholamines (norepinephrine, epinephrine). Follows the "Rule of 10s": 10% extra-adrenal (paraganglioma), 10% bilateral, 10% malignant, 10% familial (associated with MEN 2A/2B, VHL, NF1), 10% in children.
  • Clinical Presentation: Paroxysmal episodes of the 5 Ps: Pressure (severe HTN), Pain (throbbing headache), Perspiration, Palpitations, and Pallor. Diagnosis confirmed by elevated 24-hour urine or plasma free metanephrines and vanillylmandelic acid (VMA).

---

2. Neurodegenerative Pathology

Neurodegenerative diseases feature progressive, selective neuronal loss associated with aberrant accumulation of misfolded proteins.

• Alzheimer Disease (AD): Most common cause of dementia in the elderly.
  • Neuropathology:
    1. Extracellular Amyloid Plaques: Composed of beta-amyloid (A-beta42) peptides derived from sequential cleavage of Amyloid Precursor Protein (APP) by beta- and gamma-secretases. (APP gene on chromosome 21; Down syndrome patients develop early AD).
    2. Intracellular Neurofibrillary Tangles (NFTs): Flame-shaped tangles composed of hyperphosphorylated tau protein (microtubule-stabilizing protein).
  • Anatomy & Neurochemistry: Marked diffuse cortical atrophy with hydrocephalus ex vacuo; severe neuronal loss in the nucleus basalis of Meynert, causing a profound deficit in Acetylcholine (ACh) synthesis.
• Parkinson Disease (PD): Degenerative motor disorder.
  • Neuropathology: Progressive depigmentation and loss of dopaminergic neurons in the substantia nigra pars compacta of the basal ganglia. Residual neurons contain intracellular Lewy bodies, which are round eosinophilic inclusions composed of alpha-synuclein.
  • Clinical Features: Cardinal triad of resting tremor ("pill-rolling"), cogwheel rigidity, and bradykinesia/akinesia, alongside postural instability and mask-like facies.
• Amyotrophic Lateral Sclerosis (ALS / Lou Gehrig Disease):
  • Pathophysiology: Combined degeneration of upper motor neurons (UMN) in the corticospinal tract and lower motor neurons (LMN) in the anterior horns of the spinal cord and brainstem motor nuclei. Familial cases (~10%) associated with SOD1 (superoxide dismutase 1) or C9orf72 mutations.
  • Clinical Manifestations: Mixed UMN signs (spasticity, hyperreflexia, Babinski sign) and LMN signs (flaccid paralysis, muscle atrophy, fasciculations). Sensory, bowel, and bladder functions remain completely intact. Death occurs from respiratory muscle paralysis.
• Multiple Sclerosis (MS): Autoimmune demyelinating disease of the Central Nervous System (CNS).
  • Pathophysiology: Autoreactive T-cells (Th1 and Th17) cross the blood-brain barrier and target oligodendrocyte myelin antigens, producing perivenular inflammatory demyelinating plaques in CNS white matter.
  • Clinical Manifestations: Relapsing-remitting neurological deficits separated in time and space. Optic neuritis (sudden painful vision loss), Internuclear Ophthalmoplegia (INO) due to lesion in the medial longitudinal fasciculus (MLF), Lhermitte sign, and neurogenic bladder.
  • Diagnostics: MRI shows periventricular white matter demyelinating plaques ("Dawson fingers"). CSF analysis demonstrates elevated IgG index and oligoclonal bands on agarose gel electrophoresis.

---

3. Epidemiological and Public Health Principles

Epidemiology provides quantitative methods for analyzing disease distribution and causality in populations.

Measures of Disease Occurrence

• Incidence: The number of new cases of a disease developing in a population at risk over a specified time period. Measures disease risk.
• Prevalence: The total number of all existing cases (new and old) in a given population at a specific point or interval in time. Measures disease burden. Prevalence is approximately equal to Incidence multiplied by Duration.

Study Designs & Association Measures

1. Cross-Sectional Study: Assesses exposure and disease status simultaneously at a single point in time ("snapshot"). Measures Prevalence. Cannot establish temporal sequence or causality.
2. Case-Control Study: Retrospective design comparing individuals with disease (cases) to individuals without disease (controls) to evaluate past exposure frequency. Measures Odds Ratio (OR). Ideal for rare diseases.
3. Cohort Study: Prospective or retrospective design comparing an exposed group to an unexposed group over time to monitor disease development. Measures Relative Risk (RR) (Incidence in exposed divided by Incidence in unexposed).
4. Randomized Controlled Trial (RCT): Experimental gold standard for assessing therapeutic interventions. Features random assignment, double-blinding, and placebo control to minimize confounding and bias.

Diagnostic & Screening Test Performance

Screening tests evaluate asymptomatic populations to categorize individuals by probability of disease.